Published in Leukemia on August 01, 1989
CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood (1994) 2.33
Benign transient hyperphosphatasemia in children with leukemia and lymphoma. Clin Pediatr (Phila) (1996) 1.60
Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology (2004) 1.41
Interrelationship between adenylate cyclase activity, adenosine 3':5' cyclic monophosphate phosphodiesterase activity, adenosine 3':5' cyclic monophosphate levels, and growth of cells in culture. Proc Natl Acad Sci U S A (1973) 1.28
A mutant of 3T3 cells with cyclic AMP metabolism sensitive to temperature change. Proc Natl Acad Sci U S A (1973) 1.24
Antineoplastic activity of cannabinoids. J Natl Cancer Inst (1975) 1.14
Human T lymphocyte mitogenesis in response to the B oligomer of pertussis toxin is associated with an early elevation in cytosolic calcium concentrations. FEBS Lett (1987) 1.05
Evidence for the existence of specific cannabinoid binding sites. Life Sci (1978) 1.03
The role of adrenocorticotropin and calcium in adenosine cyclic 3', 5'-phosphate production and steroid release from the isolated, perfused cat adrenal gland. Mol Pharmacol (1971) 1.02
Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1. Cancer Res (1992) 0.98
Antagonism of the behavioral effects of morphine and methadone by narcotic antagonists in the pigeon. J Pharmacol Exp Ther (1970) 0.97
gamma-Interferon plays a key role in T-cell-induced tumor regression. Cancer Res (1993) 0.96
Further studies on the relationship between cycl AMP levels and adrenocortical activity. Endocrinology (1972) 0.91
The alterative effect of isobutylmethylxanthine in hypofunctional human neutrophil chemotaxis. Biochem Biophys Res Commun (1982) 0.90
Angiofollicular lymph node hyperplasia (Castleman's disease) in an adolescent female. Clinical and immunologic findings. Cancer (1991) 0.89
N6-substituted adenines induce cell elongation irrespective of the intracellular cyclic AMP levels. Exp Cell Res (1974) 0.89
Role of calcium and adenosine cyclic 3'-5' phosphate in action of adrenocorticotropin. Nat New Biol (1972) 0.88
Receptors for peanut agglutinin (Arachus hypogea) in childhood acute lymphoblastic leukemia: possible clinical significance. Blood (1980) 0.87
Coordination and reversibility of signals for proliferative activation and interleukin-2 mRNA production in resting human T lymphocytes by phorbol ester and calcium ionophore. J Biol Chem (1988) 0.86
Simian virus 40 rapidly lowers cAMP levels in mouse cells. Biochem Biophys Res Commun (1973) 0.86
Corticosteroids inhibit the delivery of short-term activational pulses of phorbol ester and calcium ionophore to human peripheral T cells. Cell Immunol (1992) 0.86
A method for the evaluation of dose-effect data utilizing a programmable calculator. J Environ Pathol Toxicol (1980) 0.85
Development of the adult respiratory distress syndrome: progressive alteration of neutrophil chemotactic and secretory processes. Am J Pathol (1984) 0.85
A unifying concept for assessing toxicological interactions: changes in slope. Toxicol Sci (2005) 0.85
Subcutaneous fat necrosis of the newborn. Pediatr Radiol (1999) 0.84
Expansion and tumour specific cytokine secretion of bryostatin-activated T-cells from cryopreserved axillary lymph nodes of breast cancer patients. Surg Oncol (1993) 0.84
Bryostatin 1-activated T cells can traffic and mediate tumor regression. J Surg Res (1992) 0.84
Reversible inhibition of ACTH-induced corticosteroid release by cycloheximide: evidence for an unidentified cellular messenger. Endocrinology (1973) 0.84
Modulation of phagocytosis by tumor promoters and epidermal growth factor in normal and transformed macrophages. Cancer Res (1980) 0.83
Alternatives to splenectomy in the management of chronic idiopathic thrombocytopenic purpura in childhood. Am J Pediatr Hematol Oncol (1984) 0.83
Application of response surface methods for evaluating the interactions of soman, atropine, and pralidioxime chloride. Fundam Appl Toxicol (1985) 0.82
Application of response-surface methodology to detect interactions of genotoxic agents in cultured mammalian cells. J Toxicol Environ Health (1986) 0.82
The role of calcium in macrophage chemotaxis to the phorbol ester tumor promoter TPA. Cell Calcium (1982) 0.82
Effects of delta9-tetrahydrocannabinol in Lewis lung adenocarcinoma cells in tissue culture. J Natl Cancer Inst (1976) 0.81
Humoral and cell-mediated immune status in mice exposed to trichloroethylene in the drinking water. Toxicol Appl Pharmacol (1982) 0.81
Ultrastructural and immunologic studies of leukocytes which form rosettes with mouse erythrocytes in human lymphocytic leukemia. J Reticuloendothel Soc (1979) 0.81
Cytotoxicity, mutagenicity, and tumorigenicity of mainstream smoke from three reference cigarettes machine-smoked to the same yields of total particulate matter per cigarette. Food Chem Toxicol (2009) 0.80
Alteration of human granulocyte functional responses by menadione. Arch Biochem Biophys (1990) 0.80
Immunologic evaluation of long-term effects of childhood ALL chemotherapy: analysis of in vitro NK- and K-cell activities of peripheral blood lymphocytes. Am J Hematol (1982) 0.79
Prednisone treatment of acute idiopathic thrombocytopenic purpura of childhood. Advantages. Am J Pediatr Hematol Oncol (1984) 0.79
A correlation between phorbol diester-induced protein phosphorylation and superoxide anion generation in HL-60 cells during granulocytic maturation. J Biol Chem (1987) 0.79
Estimation and analysis of the concentration-response surfaces associated with multiple-agent combinations. Toxicol Appl Pharmacol (1986) 0.79
Interactive effects of pertussis toxin and the phorbol ester tumour promotor, phorbol dibutyrate, on T-lymphocyte mitogenesis and the expression of phenotypic determinants. Immunology (1989) 0.78
Aplastic anemia and Down's syndrome. Pediatrics (1982) 0.78
The evaluation of biological interactions using response surface methodology. Cell Biol Toxicol (1987) 0.78
Immunologic and clinicopathologic features of common acute lymphoblastic leukemia antigen-positive childhood T-cell leukemia. A Pediatric Oncology Group Study. Cancer (1987) 0.78
Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters. Cancer Res (1981) 0.78
Caffeine elicited withdrawal signs in morphine-dependent rhesus monkeys. Eur J Pharmacol (1978) 0.77
Analysis of anticonvulsant and neurotoxic responses to combination therapy with carbamazepine, felbamate and phenytoin by response-surface modeling. Arzneimittelforschung (1995) 0.77
Kepone: cellular sites of action. Toxicol Appl Pharmacol (1979) 0.77
Role of cyclic 3'5' adenosine monophosphate on corticosteroid synthesis and release from the intact adrenal gland. Biochem Biophys Res Commun (1972) 0.77
An update in pediatric oncology. Pediatr Dent (1990) 0.77
Assessing the efficacy of azaprophen and physostigmine as a pretreatment for soman-induced incapacitation in guinea pigs by response-surface modeling. Fundam Appl Toxicol (1990) 0.77
The inhibition of DNA synthesis by cannabinoids. Cancer Res (1976) 0.77
Modulation of serum-stimulated DNA synthesis in cultured human fibroblasts by cAMP. Exp Cell Res (1977) 0.77
Assessing pyridostigmine efficacy by response surface modeling. Fundam Appl Toxicol (1985) 0.77
Effects of ruthenium red, A23187 and D-600 on steroidogenesis in Y-1 cells. Biochim Biophys Acta (1978) 0.77
Calcium modulation of phorbol ester-induced alterations in murine macrophage morphology. Cancer Res (1983) 0.76
Enzyme alterations in leukemic cells. Am J Hematol (1982) 0.76
Limitations of cigarette machine smoking regimens. Toxicol Lett (2011) 0.76
Induction of chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters. Cancer Res (1981) 0.76
Induction of the expression of differentiation-related antigens on human colon carcinoma cells by stimulating protein kinase C. Arch Surg (1990) 0.76
Maternal satisfaction with computer integrated patient controlled epidural analgesia. Anaesthesia (2006) 0.75
Inhibition of rat brain mitochondrial calcium transport by chlordecone. Toxicol Appl Pharmacol (1979) 0.75
Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+. Cancer Res (1988) 0.75
Responsiveness of guinea pig alveolar cells. Lung (1988) 0.75
Biochemical characteristics of phagocytosis in the P388 D1 cell. Exp Cell Res (1978) 0.75
Phenytoin-associated thrombocytopenia in a toddler. J Child Neurol (1999) 0.75
Evaluation of the interaction of three genotoxic agents in eliciting sister-chromatid exchanges using response surface methodology. Fundam Appl Toxicol (1987) 0.75
Monte Carlo computer simulations of ground-based and space-based coherent DIAL water vapor profiling. Appl Opt (1989) 0.75
A comparison of serum-free media for the support of in vitro mitogen-induced blastogenic expansion of cytolytic lymphocytes. Cytotechnology (1991) 0.75
The spectrum of myositis ossiticans in haemophilia. Haemophilia (2004) 0.75
An analysis of the presence of Fc receptors on bone marrow lymphoblasts in acute lymphoblastic leukemia. A Pediatric Oncology Group study. Cancer (1985) 0.75
Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure. Fundam Appl Toxicol (1990) 0.75
The relationship between lysosomal enzyme release and protein phosphorylation in human monocytes stimulated by phorbol esters and opsonized zymosan. J Biol Chem (1987) 0.75
Clinical and immunological correlates of leukemia cutis in childhood. Cancer (1982) 0.75
Mathematical and biostatistical methods for designing and analyzing complex chemical interactions. Fundam Appl Toxicol (1988) 0.75
Comparing the response surfaces of two cholinolytics when used in combination with physostigmine as a pretreatment against organophosphate challenge. Drug Chem Toxicol (1990) 0.75
Aplastic anemia following therapy for absence seizures with ethosuximide. Pediatr Neurol (1994) 0.75
Efficacy of lengthy therapy in childhood acute lymphoblastic leukemia. Va Med (1983) 0.75
Ultrastructural analysis of acute lymphoblastic cells: peanut lectin binding correlates with degree of differentiation of the leukemic cells. Exp Hematol (1985) 0.75
Young children with orthopedic handicaps: self-knowledge about their disability. Except Child (1988) 0.75
A comparative study of the disposition of (-)-delta 9-tetrahydrocannabinol in neuroblastoma and glioma cells in tissue culture: relation cellular impairment. Mol Pharmacol (1977) 0.75
Unusual presentation of Ewing sarcoma with t(21;22) in a 3-year-old boy. J Pediatr Hematol Oncol (1996) 0.75
Childhood leukemia with simultaneously expressed myeloid and lymphoid markers suggesting stem cell origin. Am J Hematol (1985) 0.75
Vindesine: a phase II study in childhood malignancies-a report for cancer and leukemia group B. Med Pediatr Oncol (1982) 0.75
PSYCHOSIS FOLLOWING CATARACT OPERATIONS: REPORT OF THREE CASES. Ann Surg (1935) 0.75
Thermal regulation of FMLP receptors on human neutrophils. J Leukoc Biol (1989) 0.75
Lymphomas and bone tumors: clinical presentation, management, and potential late effects of current treatment strategies. Adolesc Med (1999) 0.75
Characterization of non-human primate antisera to acute lymphoblastic leukemia (ALL): evidence for unique antigen(s) on childhood ALL of "T" phenotype. Blood (1983) 0.75
Evaluation of a two-drug combination pretreatment against organophosphorus exposure. Toxicol Appl Pharmacol (1990) 0.75
Inhibition of cortiocosteroidogenesis by delta-9-tetrahydrocannabinol. Endocrinology (1977) 0.75
Macrophage spreading disparity: alveolar vs peritoneal. J Clin Lab Immunol (1988) 0.75
Human acute myelogenous leukemia antigens defined by simian antisera: evidence for leukemia-associated antigens distinct from immune response-associated alloantigens. J Natl Cancer Inst (1979) 0.75